Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
5Y CAGR+12.9%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
+12.9%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
1.8x
Solid growth
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$819000.00+1.0%
2024$811000.00-
2023$0.00-
2022$0.00-100.0%
2021$524000.00+17.2%
2020$447000.00+6.4%
2019$420089.00+728.2%
2018$50721.00-9.3%
2017$55938.00-27.8%
2016$77523.00-